aTyr Pharma (LIFE)
(Delayed Data from NSDQ)
$1.69 USD
-0.03 (-1.74%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.68 -0.01 (-0.59%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.22 |
EPS Last Quarter | -0.23 |
Last EPS Surprise | 4.17% |
ABR | 1.33 |
Earnings ESP
|
13.64% |
---|---|
Current Year | -0.89 |
Next Year | -0.74 |
EPS (TTM) | -0.90 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.12M | 0.13M | 0.37M | 12.60M |
# of Estimates | 1 | 1 | 2 | 1 |
High Estimate | 0.12M | 0.13M | 0.50M | 12.60M |
Low Estimate | 0.12M | 0.13M | 0.24M | 12.60M |
Year ago Sales | 0.00M | 0.35M | 0.35M | 0.37M |
Year over Year Growth Est. | NA | -62.86% | 3.97% | 3,333.24% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.22 | -0.22 | -0.89 | -0.74 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | -0.97 |
High Estimate | -0.19 | -0.18 | -0.77 | -0.51 |
Low Estimate | -0.25 | -0.26 | -1.01 | -0.97 |
Year ago EPS | -0.22 | -0.20 | -0.94 | -0.89 |
Year over Year Growth Est. | 0.00% | -10.00% | 5.32% | 16.85% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 2 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.22 | -0.22 | -0.89 | -0.74 |
7 Days Ago | -0.22 | -0.22 | -0.89 | -0.74 |
30 Days Ago | -0.24 | -0.25 | -0.97 | -1.04 |
60 Days Ago | NA | NA | -0.77 | -0.93 |
90 Days Ago | -0.24 | -0.25 | -0.77 | -0.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.18 | -0.77 | -0.74 |
Zacks Consensus Estimate | -0.22 | -0.22 | -0.89 | -0.74 |
Earnings ESP | 13.64% | 18.18% | 13.48% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.23 | -0.25 | -0.20 | -0.22 | NA |
Estimate | -0.24 | -0.23 | -0.21 | -0.27 | NA |
Difference | 0.01 | -0.02 | 0.01 | 0.05 | 0.01 |
Surprise | 4.17% | -8.70% | 4.76% | 18.52% | 4.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more